Editorial: Difficult and severe asthma in children, volume II

Frontiers in Pediatrics

Pediatrics

Francesca Santamaria¹  Nicola Ullmann²  Renato Cutrera²  Giorgio Piacentini³  Andrew Bush⁴ 

[1] Department of Translational Medical Sciences, Pediatric Pulmonology, Federico II University, Naples, Italy;Pneumology and Cystic Fibrosis Unit, Academic Department of Pediatrics, Bambino Gesù Children’s Hospital, Rome, Italy;Professor of Paediatrics and Head of Paediatric Section AOUI Verona, University of Verona, Verona, Italy;Professor of Paediatrics, National Heart and Lung Institute, Imperial College London, London, United Kingdom;Professor of Paediatrics and Paediatric Respirology, National Heart and Lung Institute, London, United Kingdom;Consultant Paediatric Chest Physician, Royal Brompton Harefield NHS Foundation Trust, London, United Kingdom;

关键词: severe asthma;    children;    treatment;    mepolizumab;    dupilumab;    omalizumab;    airway inflammation;   

DOI  :  10.3389/fped.2023.1158309

 received in 2023-02-03, accepted in 2023-02-27,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
© 2023 Ullmann, Bush, Piacentini, Santamaria and Cutrera.